Comorbidity burden and adverse outcomes after transcatheter aortic valve replacement

Daniel R. Feldman, Mikhail D. Romashko, Benjamin Koethe, Sonika Patel, Hassan Rastegar, Yong Zhan, Charles D. Resor, Annie C. Connors, Carey Kimmelstiel, David Allen, Andrew R. Weintraub, Benjamin S. Wessler

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

BACKGROUND: Transcatheter aortic valve replacement (TAVR) has become the preferred treatment for symptomatic patients with aortic stenosis and elevated procedural risk. Many deaths following TAVR are because of noncardiac causes and co-morbid disease burden may be a major determinant of postprocedure outcomes. The prevalence of comorbid conditions and associations with outcomes after TAVR has not been studied. METHODS AND RESULTS: This was a retrospective single-center study of patients treated with TAVR from January 2015 to October 2018. The association between 21 chronic conditions and short-and medium-term outcomes was assessed. A total of 341 patients underwent TAVR and had 1-year follow-up. The mean age was 81.4 (SD 8.0) years with a mean Society of Thoracic Surgeons predicted risk of mortality score of 6.7% (SD 4.8). Two hundred twenty (65%) patients had ≥4 chronic conditions present at the time of TAVR. There was modest correlation between Society of Thoracic Surgeons predicted risk of mortality and comorbid disease burden (r=0.32, P<0.001). After adjusting for Society of Thoracic Surgeons predicted risk of mortality, age, and vascular access, each additional comorbid condition was associated with increased rates of 30-day rehospitalizations (odds ratio, 1.21; 95% CI, 1.02–1.44), a composite of 30-day rehospitalization and 30-day mortality (odds ratio, 1.20; 95% CI, 1.02–1.42), and 1-year mortality (odds ratio, 1.29; 95% CI, 1.05–1.59). CONCLUSIONS: Comorbid disease burden is associated with worse clinical outcomes in high-risk patients treated with TAVR. The risks associated with comorbid disease burden are not adequately captured by standard risk assessment. A systematic assessment of comorbid conditions may improve risk stratification efforts.

Original languageEnglish
Article numbere018978
JournalJournal of the American Heart Association
Volume10
Issue number10
DOIs
StatePublished - 2021
Externally publishedYes

Keywords

  • Cardiac disease
  • Cardiovascular disease risk factors
  • Clinical cardiology
  • Transcatheter aortic valve implantation

Fingerprint

Dive into the research topics of 'Comorbidity burden and adverse outcomes after transcatheter aortic valve replacement'. Together they form a unique fingerprint.

Cite this